Bottom line
Is DMCRX a good fund? The bottom line
DMCRX is an actively managed small-cap mutual fund from Driehaus Mutual.
It returned +30.9% over one year, +9.6% a year over five years, +19.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $597 million in net assets and 133 holdings, its largest position is Definium Therapeutics Inc (2.4%) and the top 10 make up 17.9% of the portfolio.
What stands out
- 5-year return beat 77% of category peers
- No front-end sales load
What to watch
- High turnover (142% a year) can mean more taxable distributions
Updated Nov 19, 2026
What DMCRX invests in
Driehaus Micro Cap Growth Fund seeks to maximize capital appreciation.
The Fund uses a growth style of investment in equity securities, including common stocks and other equity securities of issuers. Under normal market conditions, the Fund invests at least 80% of its net assets (plus the amount of borrowings for investment purposes) in the equity securities of U.S. micro-capitalization (micro-cap) companies. For purposes of the Fund, the investment adviser considers a company to be a micro-cap company if it is within the same market capitalization range at the time of investment as those included in the Russell Microcap Growth Index. For the avoidance of doubt, while the reference index is float-adjusted, meaning it excludes closely held and other shares unavailable to investors, the investment adviser does not consider a float-adjustment when determining the market capitalization of a company. As of March 31, 2026, approximately 87% of the Russell…
From the fund's prospectus (filed Apr 29, 2026).
DMCRX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DMCRX | +30.9% | +9.6% | +19.6% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
DMCRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Definium Therapeutics Inc DFTX | 2.43% |
| 2 | Praxis Precision Medicines Inc PRAX | 2.06% |
| 3 | Spyre Therapeutics Inc SYRE | 2.00% |
| 4 | Ultra Clean Holdings Inc UCTT | 1.95% |
| 5 | Cardinal Infrastructure Group Inc CDNL | 1.90% |
| 6 | Ceco Environmental Corp CECO | 1.73% |
| 7 | Nlight Inc LASR | 1.57% |
| 8 | Xometry Inc XMTR | 1.49% |
| 9 | Silicon Motion Technology Corp SIMO | 1.42% |
| 10 | Edgewise Therapeutics Inc EWTX | 1.41% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 17.9% of the fund. See all top 25 holdings and asset mix →